Congressional committee investigates former NCI Director Richard Klausner’s role in $40 million Harvard contract; NIH begins internal review. Klausner: investigation casts “strange innuendoes.” Text of committee’s letter.
Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.
NCI program announcement available, contract awards listed.
